KWMG
LEGN icon

King Wealth Management Group’s Legend Biotech LEGN Stock Holding History

King Wealth Management Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,000
Closed -$436K – 172
2022
Q1 		$436K Buy
+12,000
New +$474K 0.09% 96

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

King Wealth Management Group's LEGN Position: Q2 2022 in Review

King Wealth Management Group sold out of Legend Biotech (LEGN) in Q2 2022, closing a stake of 12,000 shares — an estimated $436K sold.

King Wealth Management Group first reported a position in LEGN in Q1 2022 and held it in 1 quarter. The position peaked at $436K in Q1 2022. 150 funds tracked by Wall St. Rank hold LEGN as of Q2 2022.

  • King Wealth Management Group reported no remaining Legend Biotech position as of Q2 2022 after selling out during the quarter.
  • King Wealth Management Group sold 12,000 Legend Biotech shares in Q2 2022, an estimated $436K.
  • King Wealth Management Group first reported a position in Legend Biotech in Q1 2022 and held it in 1 quarter.
  • King Wealth Management Group's Legend Biotech position peaked at $436K in Q1 2022.
  • 150 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2022.

Based on King Wealth Management Group's 13F filing for Q2 2022, filed 11 Aug 2022.